Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Bruce A Goldberger, Chris W Chronister, Michele L Merves
Index: Methods Mol. Biol. 603 , 75-87, (2010)
Full Text: HTML
Abstract
The benzodiazepine assay utilizes gas chromatography-mass spectrometry (GC-MS) for the analysis of diazepam, nordiazepam, oxazepam, temazepam, lorazepam, alpha-hydroxyalprazolam, and alpha-hydroxytriazolam in blood and urine. A separate assay is employed for the analysis of alprazolam. Prior to solid phase extraction, urine specimens are subjected to enzyme hydrolysis. The specimens are fortified with deuterated internal standard and a five-point calibration curve is constructed. Specimens are extracted by mixed-mode solid phase extraction. The benzodiazepine extracts are derivatized with N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (MTBSFTA) producing tert-butyldimethyl silyl derivatives; the alprazolam extracts are reconstituted in methanol without derivatization. The final extracts are then analyzed using selected ion monitoring GC-MS.
Related Compounds
Related Articles:
2015-01-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 975 , 24-33, (2014)]
2005-05-05
[J. Med. Chem. 48 , 3269-79, (2005)]
2014-10-01
[Forensic Sci. Int. 243 , 99-106, (2014)]
2014-10-01
[Forensic Sci. Int. 243 , 149-55, (2014)]
2014-11-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014)]